Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SOD1 | P00441 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2427421 | 0.99 | CYP3A4 (0.33) | CYP3A4CYP2C9CYP2C19GRM2LMNA | |
| Hydrochloric Acid SCHEMBL2384262 | 0.88 | — | — | |
| SCHEMBL5090534 | 0.85 | GRM2 (0.33) | CYP3A4CYP2C9CYP2C19GRM2LMNA | |
| SCHEMBL7539127 | 0.85 | GRM2 (0.35) | CYP3A4CYP2C9CYP2C19GRM2LMNA | |
| Hydrochloric Acid SCHEMBL2383716 | 0.84 | GRM2 (0.32) | CYP3A4CYP2C9CYP2C19GRM2LMNA | |
| Hydrochloric Acid SCHEMBL2382831 | 0.84 | GRM2 (0.34) | CYP3A4CYP2C9CYP2C19GRM2LMNA | |
| Hydrochloric Acid SCHEMBL2382946 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL2383290 | 0.83 | — | — | |
| SCHEMBL4087717 | 0.83 | CYP3A4 (0.35) | CYP3A4CYP2C9CYP2C19GRM2LMNA | |
| Hydrochloric Acid SCHEMBL2384101 | 0.83 | ACHE (0.34) | GRM2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100063228-A1 | TRANSITION METAL COMPLEX, PROCESS FOR PRODUCING THE SAME, AND USE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063228-A1 | TRANSITION METAL COMPLEX, PROCESS FOR PRODUCING THE SAME, AND USE | CPN1, CYC1, AP1M1 | CYP3A4 835/4885CYP2C9 1806/4885CYP2C19 1530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.